In 2025, the global health economics and outcomes research market is expected to be valued at approximately USD 1.70 billion. HEOR is essential for evaluating the cost-effectiveness, economic impact, and health outcomes of various healthcare interventions and treatments. The market is growing as pharmaceutical companies, healthcare providers, and payers increasingly rely on HEOR data to support product development, reimbursement decisions, and regulatory submissions.Rising healthcare costs, the need for improved patient care, and a shift toward value-based healthcare models are all contributing to the demand for health economics and outcomes research. The market is also being bolstered by advancements in data analytics, increasing integration of technology, and the need for healthcare solutions that improve both economic and clinical outcomes.
Projected Growth and Market Outlook (2026–2035)
The global health economics and outcomes research market is projected to grow at a compound annual growth rate (CAGR) of 13.50% from 2026 to 2035. By 2035, the market is expected to reach USD 6.03 billion. This growth is driven by factors such as the increasing focus on personalized medicine, advancements in healthcare technology, and the growing importance of demonstrating the value of treatments to regulators, payers, and patients.
Get a Free Sample Report with Table of Contents: Click Here
Key Drivers of Growth
Rising Demand for Cost-Effective Healthcare Solutions: As healthcare spending continues to rise globally, there is a growing demand for cost-effective solutions. Health economics and outcomes research plays a vital role in determining which treatments offer the best value for money. By providing evidence of the cost-effectiveness of interventions, HEOR supports the decision-making process of healthcare providers, payers, and government bodies, thereby driving market demand.
Mergers and Acquisitions in the Healthcare Sector: The ongoing trend of mergers and acquisitions (M&A) among leading healthcare companies is boosting the demand for health economics and outcomes research. As large pharmaceutical companies consolidate, they require more comprehensive HEOR data to inform product development, market access, and reimbursement strategies. These M&A activities are helping to accelerate the adoption of HEOR in the global healthcare industry.
Shift Toward Value-Based Healthcare: The global healthcare industry is increasingly shifting toward value-based care, where the emphasis is placed on improving health outcomes while controlling costs. HEOR plays a critical role in this transition by providing evidence of the long-term benefits of various treatments, which is essential for determining the value of healthcare interventions in a value-based model.
Technological Advancements in Data Analytics: Advancements in big data, artificial intelligence (AI), and machine learning are enabling more sophisticated and accurate health economics and outcomes research. These technologies allow for the analysis of large datasets to identify trends, predict outcomes, and optimize resource allocation in healthcare systems. As a result, the demand for HEOR services is expected to grow, particularly in sectors like pharmaceutical research and healthcare policy.